Ticker

Analyst Price Targets — PRCT

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 5, 2026 12:53 pmTruist Financial$21.00$18.27TheFly Procept BioRobotics price target lowered to $21 from $25 at Truist
August 5, 2026 12:11 pmEvercore ISI$23.00$18.63TheFly Procept BioRobotics price target lowered to $23 from $30 at Evercore ISI
August 5, 2026 11:33 amRobert W. Baird$20.00$18.28TheFly Procept BioRobotics price target lowered to $20 from $24 at Baird
August 5, 2026 11:25 amPiper Sandler$25.00$18.28TheFly Procept BioRobotics price target lowered to $25 from $35 at Piper Sandler
August 5, 2026 11:14 amNathan TreybeckWells Fargo$19.00$18.28TheFly Procept BioRobotics downgraded to Equal Weight from Overweight at Wells Fargo
August 5, 2026 11:07 amMichael SarconeJefferies$20.00$18.64StreetInsider Procept BioRobotics Corp (PRCT) PT Lowered to $20 at Jefferies
July 28, 2026 10:46 amUBS$20.00$17.69TheFly Procept BioRobotics assumed with Neutral from Buy at UBS
July 2, 2026 8:06 pmTruist Financial$25.00$21.03TheFly Procept BioRobotics downgraded to Hold from Buy at Truist
June 24, 2026 10:05 amVijay KumarEvercore ISI$30.00$20.60TheFly Procept BioRobotics initiated with an Outperform at Evercore ISI
June 11, 2026 10:06 amLeerink Partners$29.00$29.09TheFly Procept BioRobotics downgraded to Market Perform from Outperform at Leerink

Latest News for PRCT

PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT

NEW ORLEANS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation (NasdaqGM: PRCT) (“Procept” or the “Company”), if they purchased the Company's shares between February 28, 2024 and February 25, 2026, inclusive…

GlobeNewsWire • Sep 2, 2026
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - September 2, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or the "Company")…

Newsfile Corp • Sep 2, 2026
PRCT FINAL DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – PRCT

NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”), of the important September 22, 2026 lead plaintiff deadline.

GlobeNewsWire • Sep 2, 2026
PRCT FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages PROCEPT BioRobotics Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - PRCT

New York, New York--(Newsfile Corp. - September 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) between February 28, 2024 and February 25, 2026, inclusive (the "Class Period"), of the important September 22, 2026 lead plaintiff deadline. SO WHAT: If you purchased PROCEPT common stock during the Class Period you…

Newsfile Corp • Sep 2, 2026
PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP

SAN FRANCISCO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) that a securities class action has been filed after repeated surprise unit handpiece sales underperformance and gradual revelations of excess customer inventory levels driven by repeated, late-quarter, bulk discounts.

GlobeNewsWire • Sep 2, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for PRCT.

No House trades found for PRCT.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top